PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE: CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024.
Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medicaid, Marketplace and Medicare products.
"Charlene helped drive explosive growth in our Marketplace product, and was instrumental in Florida's successful Medicaid contract reprocurement," said Centene CEO of Markets and Medicaid, Nathan Landsbaum. "Her leadership in this new role will expand her impact and help fuel Sunshine Health's continued growth and dedicated service to our members, providers and the community."
"I am excited for this opportunity to serve and ensure that Floridians have access to high-quality comprehensive healthcare," said Zein. "I look forward to working with our government, provider and community partners to support people on their journeys to better health and overall wellness."
Sunshine Health provides health coverage for over 2.5 million Floridians through its Medicaid, Marketplace and Medicare products. For more about Sunshine Health, visit SunshineHealth.com.
About Sunshine Health
Headquartered in Broward County with offices across the state, Sunshine Health is among the largest healthcare plans in Florida. Offering coordinated care and a network of support for our members, Sunshine Health is transforming the health of the community, one person at a time. It offers government-sponsored managed care through Medicaid, Long Term Care, the Health Insurance Marketplace (Ambetter Health), and Medicare Advantage and Prescription Drug Plans (Wellcare). Its specialty plans include the Sunshine Health Pathways to Shine Specialty Plan serving children in or adopted from the state's Child Welfare system; the Sunshine Health Mindful Pathways Specialty Plan for people living with serious mental illness; the Sunshine Health Power to Thrive Specialty Plan (coming 2025) for people living with HIV/Aids; and the Children's Medical Services Health Plan, operated by Sunshine Health on behalf of the Florida Department of Health for children and adolescents with special healthcare needs. Sunshine Health is a Centene Corporation company. For more information, visit SunshineHealth.com or follow us on Facebook and Twitter @SunHealthFL.
Last Trade: | US$59.10 |
Daily Change: | 1.29 2.23 |
Daily Volume: | 4,074,504 |
Market Cap: | US$29.840B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB